Hopes for a drug that could inhibit colorectal cancer took a knock last year due to revelations of serious side-effects. But a combination therapy may now offer a way forward.
Could COX-2s stage a comeback in cancer?
Janet Fricker
Related Articles
News
Early-phase trials are moving away from the “big killers”
Cutting Edge
Don’t shoot the driver! It’s about taxonomy more than targets
Senza categoria